Summary
Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it. API also refers to the active or central ingredient in the product which causes the direct effect on the disease diagnosis, prevention, treatment or cure. While API is the active component of a drug, excipients are the inactive or inert substances present in a drug.
The global Active Pharmaceutical Ingredient market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major Application
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
Teva
Novartis
Pfizer
Johnson & Johnson
Mylan
North China Pharmaceutical Group
Dr. Reddy’s Laboratories
Roche
Aurobindo pharma
Sun Pharmaceutical Industries
Boehringer Ingelheim GmbH
Bayer
BASF
DSM
Zhejiang Medicine
Biocon
Johnson Matthey
Hisun Pharmacy
Cambrex
Shandong Xinhua Pharmaceutical
Lonza group
Huahai Pharmaceutical
Haerbin Pharmaceutical Group
Cipla
Tian Yao
Lupin
North East Pharmaceutical
Albemarle
Shandong Lukang Pharmaceutical
Jiangsu Hengrui Medicine
Bachem
Major applications as follows:
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Oncology Drugs
Anti-diabetic Drugs
Cardiovascular Drugs
Central Nervous System Drugs (CNS Drugs)
Musculoskeletal Drugs
Other Drugs
Major Type as follows:
Synthetic API
Biotech API
Others
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents
1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Type
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 Teva
3.1.1 Company Information
3.1.2 Product & Services
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.1.4 Recent Development
3.2 Novartis
3.2.1 Company Information
3.2.2 Product & Services
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2.4 Recent Development
3.3 Pfizer
3.3.1 Company Information
3.3.2 Product & Services
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3.4 Recent Development
3.4 Johnson & Johnson
3.4.1 Company Information
3.4.2 Product & Services
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4.4 Recent Development
3.5 Mylan
3.5.1 Company Information
3.5.2 Product & Services
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5.4 Recent Development
3.6 North China Pharmaceutical Group
3.6.1 Company Information
3.6.2 Product & Services
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6.4 Recent Development
3.7 Dr. Reddy’s Laboratories
3.7.1 Company Information
3.7.2 Product & Services
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7.4 Recent Development
3.8 Roche
3.8.1 Company Information
3.8.2 Product & Services
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8.4 Recent Development
3.9 Aurobindo pharma
3.9.1 Company Information
3.9.2 Product & Services
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9.4 Recent Development
3.10 Sun Pharmaceutical Industries
3.10.1 Company Information
3.10.2 Product & Services
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10.4 Recent Development
3.11 Boehringer Ingelheim GmbH
3.11.1 Company Information
3.11.2 Product & Services
3.11.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11.4 Recent Development
3.12 Bayer
3.12.1 Company Information
3.12.2 Product & Services
3.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.12.4 Recent Development
3.13 BASF
3.13.1 Company Information
3.13.2 Product & Services
3.13.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.13.4 Recent Development
3.14 DSM
3.14.1 Company Information
3.14.2 Product & Services
3.14.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.14.4 Recent Development
3.15 Zhejiang Medicine
3.15.1 Company Information
3.15.2 Product & Services
3.15.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.15.4 Recent Development
3.16 Biocon
3.16.1 Company Information
3.16.2 Product & Services
3.16.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.16.4 Recent Development
3.17 Johnson Matthey
3.17.1 Company Information
3.17.2 Product & Services
3.17.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.17.4 Recent Development
3.18 Hisun Pharmacy
3.18.1 Company Information
3.18.2 Product & Services
3.18.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.18.4 Recent Development
3.19 Cambrex
3.19.1 Company Information
3.19.2 Product & Services
3.19.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.19.4 Recent Development
3.20 Shandong Xinhua Pharmaceutical
3.20.1 Company Information
3.20.2 Product & Services
3.20.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.20.4 Recent Development
3.21 Lonza group
3.21.1 Company Information
3.21.2 Product & Services
3.21.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.21.4 Recent Development
3.22 Huahai Pharmaceutical
3.22.1 Company Information
3.22.2 Product & Services
3.22.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.22.4 Recent Development
3.23 Haerbin Pharmaceutical Group
3.23.1 Company Information
3.23.2 Product & Services
3.23.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.23.4 Recent Development
3.24 Cipla
3.24.1 Company Information
3.24.2 Product & Services
3.24.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.24.4 Recent Development
3.25 Tian Yao
3.25.1 Company Information
3.25.2 Product & Services
3.25.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.25.4 Recent Development
3.26 Lupin
3.26.1 Company Information
3.26.2 Product & Services
3.26.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.26.4 Recent Development
3.27 North East Pharmaceutical
3.27.1 Company Information
3.27.2 Product & Services
3.27.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.27.4 Recent Development
3.28 Albemarle
3.28.1 Company Information
3.28.2 Product & Services
3.28.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.28.4 Recent Development
3.29 Shandong Lukang Pharmaceutical
3.29.1 Company Information
3.29.2 Product & Services
3.29.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.29.4 Recent Development
3.30 Jiangsu Hengrui Medicine
3.30.1 Company Information
3.30.2 Product & Services
3.30.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.31 Bachem
4 Major Application
4.1 Non-steroidal Anti-inflammatory Drugs (NSAIDs)
4.1.1 Overview
4.1.2 Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market Size and Forecast
4.2 Oncology Drugs
4.2.1 Overview
4.2.2 Oncology Drugs Market Size and Forecast
4.3 Anti-diabetic Drugs
4.3.1 Overview
4.3.2 Anti-diabetic Drugs Market Size and Forecast
4.4 Cardiovascular Drugs
4.4.1 Overview
4.4.2 Cardiovascular Drugs Market Size and Forecast
4.5 Central Nervous System Drugs (CNS Drugs)
4.5.1 Overview
4.5.2 Central Nervous System Drugs (CNS Drugs) Market Size and Forecast
4.6 Musculoskeletal Drugs
4.6.1 Overview
4.6.2 Musculoskeletal Drugs Market Size and Forecast
4.7 Other Drugs
4.7.1 Overview
4.7.2 Other Drugs Market Size and Forecast
5 Market by Type
5.By Synthetic API
5.1 Synthetic API
5.1.1 Overview
5.1.2 Synthetic API Market Size and Forecast
5.2 Biotech API
5.2.1 Overview
5.2.2 Biotech API Market Size and Forecast
5.3 Others
5.3.1 Overview
5.3.2 Others Market Size and Forecast
6 Price Overview
6.1 Price by Manufacturers
6.2 Price by Application
6.3 Price by Type
7 Conclusion
